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Abstract
Background: Unclear pathogenesis existed for nasopharyngeal carcinoma. 
Aims: to analyze the role of  bile acids in the pathogenesis of  nasopharyngeal carcinoma. 
Methods: 20 healthy volunteers and 20 patients with nasopharyngeal carcinoma were enrolled between January 1st, 2013 and 
December 31st, 2014. ESI-QTOF-MS analysis of  serum was performed to find altered bile acids components. The biological 
function of  changed bile acids was investigated using in vitro experiment. 
Results: Compared with healthy volunteers, the level of  DCA and GDCA exhibited higher abundance in patients with 
nasopharyngeal carcinoma (p<0.01). Furthermore, the biological function was investigated for the inhibition of  DCA and 
GDCA towards the secretion of  IL-10 by CD4+CD25- T cells. Both DCA and GDCA significantly inhibited the secretion 
of  IL-10 by CD4+CD25- T cells. Furthermore, DCA+GDCA can show stronger inhibition towards the secretion of  IL-10 
than DCA and GDCA.
Conclusion: The inhibition of  IL-10 secretion by elevated DCA and GDCA components in nasopharyngeal carcinoma 
patients is the inducer for nasopharyngeal carcinoma.
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Introduction
Nasopharyngeal carcinoma (NPC) is uncommon in the 
United States and most countries of  the world. Statisti-
cal analysis demonstrated the most prevalent of  naso-
pharyngeal carcinoma in Southeast Asians1. Diagnosis 
and therapy methods are relatively poor due to it being 
relatively rare condition in Western countries. There-
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Immune function has close relationship with the patho-
genesis of  NPC. Previous literatures have shown that 
the appearance of  malignant process producing several 
immunogenic viral proteins within a context of  local 
inflammation and heavy leukocytic infiltration is one 
major paradox of  NPC pathogenesis. Additionally, the 
different TIL subsets have strong prognostic value for 
NPC patients2,3.
Bile acids are steroid acids predominantly found in bile 
of  mammals. Liver is the major organ responsible for 
the synthesis of  primary bile acids, and the function of  
bacteria in the colon is to promote the biotransforma-
tion of  primary bile acids into the secondary bile acids4. 
Bile acids exert many biological functions, including the 
elimination of  cholesterol from the body and driving 
the flow of  bile to eliminate bilirubin. Disruption of  
bile acids has been reported to be inducers of  some 
diseases, such as diabetes and cancers4. 
The present study aims to determine the bile acids com-
ponents in serum and tries to correlate the relationship 
of  bile acids with the pathogenesis of  nasopharyngeal 
carcinoma (NPC).
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Materials and methods
Chemicals antibodies and reagents
CA, DCA, CDCA, GCDCA, GDCA and GCA were 
purchased from Sigma-Aldrich (St Louis, MO). All oth-
er reagents and solvents were of  HPLC grade.
Patients and serum preparation
20 healthy volunteers (age 18-65, body weight 45-90 kg) 
and 20 patients with nasopharyngeal carcinoma (age 
17-65, body weight 48-90 kg) were enrolled between 
January 1st, 2013 and December 31st, 2014. Blood was 
taken, and serum was prepared though the centrifuga-
tion at 8,000*g for 30 min.
Bile acids analysis using UPLC-ESI-QTOFMS
Both positive and negative modes were used for UPLC-
ESI-QTOFMS running, and the full-scan mode at m/z 
100-1,000 was employed. Reverse-phase ACQUITY 
UPLC BEH C18 column (2.1×50mm) was used, and 
the gradient mobile phase was consisted of  acetonitrile 
(A) and water containing 0.2% formic acid (B). The 
following gradient was used: 0-0.5 min, 100% B; 0.5-
7.5 min, 100%B-100% A. Nitrogen was used as both 
cone gas (50 l/h) and desolvation gas (600 l/h). Source 
desolvation temperatures were set at 1200c and 3500c, 
respectively. The capillary voltage and cone voltage was 
3000 and 20 V, respectively. 
In vitro determination of  bile acids’ influence to-
wards IL-10 secretion
CD4+CD25- T cells were cultured plated bound an-
ti-CD3 (5 μg/ml) and soluble anti-CD28 (2 μg/ml) an-
tibodies in the presence or absence of  bile acids com-
ponents for 24 h. After the culture, cells were collected, 
and the protein concentration of  IL-10 was determined 
using ELISA analysis.
Statistical analysis
The experimental data was presented as mean±S.E.M. 
Comparisons between two groups were performed us-
ing a two-tailed unpaired student’s t test. A value of  
P<0.05 was considered to be statistically significant.
Results
The relative abundance of  bile acids was given in Table 
1. 
Compared with healthy volunteers, the level of  DCA 
and GDCA exhibited higher abundance in patients with 
nasopharyngeal carcinoma (p<0.01). Futhermore, the 
biological function was investigated for the inhibition 
of  DCA and GDCA towards the secretion of  IL-10 by 
CD4+CD25- Tcells. As shown in Figure 1, both DCA 
and GDCA significantly inhibited the secretion of  IL-
10 by CD4+CD25- T cells. Furthermore, DCA+GD-
CA can showed stronger inhibition towards the secre-
tion of  IL-10 than DCA and GDCA.
Table 1. The relevant abundance (The abundance of bile acids/ the abundance of 





Healthy volunteers Patients with nasopharyngeal 
carcinoma 
CA 0.25 (0.02) 0.26 (0.03) 
GCA 1.23(0.05) 1.26 (0.08) 
DCA 0.04 (0.01) 0.25 (0.01)** 
GDCA 1.25 (0.06) 1.89 (0.01)** 
CDCA 0.14 (0.05) 0.10 (0.06) 
GCDCA 0.89 (0.07) 0.95 (0.05) 
  
 
African Health Sciences Vol 15 Issue 4, December 20151201
Discussion
Metabolomics is a technology used to profile the small 
molecules in biosamples, including serum, urine, and 
some organ tissues. Metabolomics has been successful-
ly employed to elucidate the pathogenesis of  diseases 
and the toxicity mechanism of  xenobiotics. The exper-
iment carried out by Manna et al used metabolomics to 
elucidate the pathogenesis of  colon cancer5. Metabo-
lomics has also been applied in the mechanism expla-
nation of  dioxin- and diet-induced steatohepatitis in 
which inflammatory cascade plays a key role6. 
Bile acids play an important role in the pathogenesis of  
some diseases. For example, bile acids play an impor-
tant role in the pathogenesis of  obesity and diabetes7. 
The pathogenesis role of  bile acids in cancers has also 
been reported by previous literatures. For example, the 
dysregulation of  bile acids has close relationship with 
gastrointestinal cancer8. Secondary bile acids have been 
considered to be a cause of  colon cancer9. The experi-
ments performed by Liu et al. showed that conjugated 
bile acids promoted cholangiocarcinoma cell invasive 
growth through the activation of  sphingosine 1-phos-
phate receptor 210.
In this study, we found the role of  bile acids in the 
pathogenesis of  nasopharyngeal carcinoma. In patients 
Figure 1. Inhibition of DCA and GDCA towards IL-10 protein secretion by 
CD4+ T cells. Three independent experiments were carried out, and data 
were given as mean plus S.E.M. *, P<0.05 
  
 
with nasopharyngeal carcinoma, the level of  DCA and 
GDCA in serum significantly inhibited the secretion of  
IL-10 protein by T cells. These results will be helpful 
for the understanding of  nasopharyngeal carcinoma’s 
pathogenesis.
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